These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


356 related items for PubMed ID: 2123203

  • 1. Topical Bactroban (mupirocin): efficacy in treating burn wounds infected with methicillin-resistant staphylococci.
    Strock LL, Lee MM, Rutan RL, Desai MH, Robson MC, Herndon DN, Heggers JP.
    J Burn Care Rehabil; 1990; 11(5):454-9. PubMed ID: 2123203
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia.
    Jones RN, Li Q, Kohut B, Biedenbach DJ, Bell J, Turnidge JD.
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):63-71. PubMed ID: 16368476
    [Abstract] [Full Text] [Related]

  • 4. [Investigation of antibacterial activity of topical antimicrobials against methicillin-resistant Staphylococcus aureus].
    Cui S, Han L, Xiao S, Chen X, Chang Q, Liu Y, Zhang X.
    Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):21-4. PubMed ID: 24684985
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis.
    Snelling CF, Ronald AR, Waters WR, Yaworski DS, Drulak K, Sunderland M.
    Can Med Assoc J; 1978 Sep 09; 119(5):466-70. PubMed ID: 99223
    [Abstract] [Full Text] [Related]

  • 7. [Mupirocin resistance in methicillin-resistant Staphylococcus aureus strains isolated from wound infections].
    Dolapçi I, Karahan ZC, Tekeli A, Koyuncu E, Azap A, Adaleti R.
    Mikrobiyol Bul; 2007 Jul 09; 41(3):435-40. PubMed ID: 17933255
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of mupirocin in methicillin-resistant Staphylococcus aureus burn wound infection.
    Rode H, Hanslo D, de Wet PM, Millar AJ, Cywes S.
    Antimicrob Agents Chemother; 1989 Aug 09; 33(8):1358-61. PubMed ID: 2508545
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Are topical antimicrobials effective against bacteria that are highly resistant to systemic antibiotics?
    Neely AN, Gardner J, Durkee P, Warden GD, Greenhalgh DG, Gallagher JJ, Herndon DN, Tompkins RG, Kagan RJ.
    J Burn Care Res; 2009 Aug 09; 30(1):19-29. PubMed ID: 19060725
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Activity of topical antimicrobial agents against multidrug-resistant bacteria recovered from burn patients.
    Glasser JS, Guymon CH, Mende K, Wolf SE, Hospenthal DR, Murray CK.
    Burns; 2010 Dec 09; 36(8):1172-84. PubMed ID: 20542641
    [Abstract] [Full Text] [Related]

  • 14. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit.
    Jones JC, Rogers TJ, Brookmeyer P, Dunne WM, Storch GA, Coopersmith CM, Fraser VJ, Warren DK.
    Clin Infect Dis; 2007 Sep 01; 45(5):541-7. PubMed ID: 17682986
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of silver sulfadiazine 1%, mupirocin 2%, and fusidic acid 2% for topical antibacterial effect in methicillin-resistant staphylococci-infected, full-skin thickness rat burn wounds.
    Acikel C, Oncul O, Ulkur E, Bayram I, Celikoz B, Cavuslu S.
    J Burn Care Rehabil; 2003 Sep 01; 24(1):37-41. PubMed ID: 12543989
    [Abstract] [Full Text] [Related]

  • 17. In vitro susceptibility testing of meticillin-resistant and meticillin-susceptible staphylococci to mupirocin and novobiocin.
    Fulham KS, Lemarie SL, Hosgood G, Dick HL.
    Vet Dermatol; 2011 Feb 01; 22(1):88-94. PubMed ID: 21039985
    [Abstract] [Full Text] [Related]

  • 18. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.
    Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM.
    Mol Pharm; 2009 Feb 01; 6(5):1388-401. PubMed ID: 19473014
    [Abstract] [Full Text] [Related]

  • 19. In vitro evaluation of topical biocide and antimicrobial susceptibility of Staphylococcus pseudintermedius from dogs.
    Valentine BK, Dew W, Yu A, Weese JS.
    Vet Dermatol; 2012 Dec 01; 23(6):493-e95. PubMed ID: 23050904
    [Abstract] [Full Text] [Related]

  • 20. An experimental evaluation of the germicidal efficacy of three topical antimicrobial agents in burns.
    Rode H, de Wet PM, Davies MR, Cywes S.
    Prog Pediatr Surg; 1981 Dec 01; 14():189-208. PubMed ID: 7221007
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.